<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1357</article-id><article-id pub-id-type="doi">10.25208/vdv1357</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Current state of the red scrotum syndrome</article-title><trans-title-group xml:lang="ru"><trans-title>Современный взгляд на синдром красной мошонки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6550-9348</contrib-id><contrib-id contrib-id-type="spin">5805-3882</contrib-id><name-alternatives><name xml:lang="en"><surname>Abuduyev</surname><given-names>Nazirbek K.</given-names></name><name xml:lang="ru"><surname>Абудуев</surname><given-names>Назирбек Каримуллаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>abuduyevnk@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4169-4128</contrib-id><contrib-id contrib-id-type="spin">7634-5521</contrib-id><name-alternatives><name xml:lang="en"><surname>Plahova</surname><given-names>Xenia I.</given-names></name><name xml:lang="ru"><surname>Плахова</surname><given-names>Ксения Ильинична</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p></bio><email>plahova_xenia@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0599-6305</contrib-id><contrib-id contrib-id-type="spin">1598-8595</contrib-id><name-alternatives><name xml:lang="en"><surname>Katunin</surname><given-names>Georgiy L.</given-names></name><name xml:lang="ru"><surname>Катунин</surname><given-names>Георгий Леонидович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>g.katunin@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Research Center of Dermatovenereology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2022-11-01" publication-format="electronic"><day>01</day><month>11</month><year>2022</year></pub-date><pub-date date-type="pub" iso-8601-date="2022-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2022</year></pub-date><volume>98</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>53</fpage><lpage>58</lpage><history><date date-type="received" iso-8601-date="2022-08-23"><day>23</day><month>08</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-12"><day>12</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Abuduyev N.K., Plahova X.I., Katunin G.L.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Абудуев Н.К., Плахова К.И., Катунин Г.Л.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Abuduyev N.K., Plahova X.I., Katunin G.L.</copyright-holder><copyright-holder xml:lang="ru">Абудуев Н.К., Плахова К.И., Катунин Г.Л.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1357">https://vestnikdv.ru/jour/article/view/1357</self-uri><abstract xml:lang="en"><p>Red scrotum syndrome is a chronic, difficult-to-recognize dermatosis affecting middle-aged and elderly people. It is manifested by erythema of the scrotum with clear boundaries, without neck. The etiology and pathogenesis of the disease have not been established. Hypotheses about the causes of dermatosis as a consequence of uncontrolled use of topical steroids, neurological inflammation, formation of microbial biofilm are based on anamnestic data and the results of trial treatments. Etiologically and pathogenetically justified therapy has not been proposed. Therapy with the use of doxycycline, gabapentin, pregabalin, indomethacin, tacrolimus was carried out in small groups of patients. The lack of clarity in the etiology and understanding of the mechanism of development of the disease explains the lack of a unified focus of the proposed therapies based on isolated clinical cases. In general, the problem of diagnosis and treatment rests on the absence of major clinical, epidemiological and laboratory studies that allowed to establish the pathophysiology and assess the true prevalence of red scrotum syndrome.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром красной мошонки — хронический, трудно распознаваемый дерматоз, поражающий лиц среднего и пожилого возраста. Проявляется эритемой мошонки с четкими границами, без шелушения. Этиология и патогенез заболевания не установлены. Гипотезы о возникновении дерматоза в результате бесконтрольного применения топических стероидов, неврологического воспаления, образования микробной биопленки основаны на анамнестических данных и результатах пробного лечения. Этиологически и патогенетически обоснованной терапии не предложено. Терапия с применением доксициклина, габапентина, прегабалина, индометацина, такролимуса проводилась небольшим группам больных. Отсутствие ясности в этиологии и понимании механизма развития заболевания объясняет отсутствие единой направленности предложенных методов терапии, основанных на единичных клинических случаях. В целом проблема диагностики и лечения упирается в отсутствие крупных клинико-эпидемиологического и лабораторного исследований, которые позволили бы установить патофизиологию процесса и оценить истинную распространенность синдрома красной мошонки.</p></trans-abstract><kwd-group xml:lang="en"><kwd>red scrotum syndrome</kwd><kwd>poststeroidal vasodilation</kwd><kwd>erythromelalgia</kwd><kwd>microbial biofilm</kwd><kwd>doxycycline</kwd><kwd>gabapentin</kwd><kwd>pregabalin</kwd><kwd>ivermectin</kwd><kwd>indomethacin</kwd><kwd>tacrolimus</kwd><kwd>timоlol</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром красной мошонки</kwd><kwd>вазодилатация постстероидная</kwd><kwd>эритромелалгия</kwd><kwd>микробная биопленка</kwd><kwd>доксициклин</kwd><kwd>габапентин</kwd><kwd>прегабалин</kwd><kwd>ивермектин</kwd><kwd>индометацин</kwd><kwd>такролимус</kwd><kwd>тимолол</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Fisher BK. The red scrotum syndrome. Cutis. 1997;60(3):139–141.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Rubin MB. Red scrotum syndrome. Cutis. 1998;61(1):28D.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Rapaport MJ. Red scrotum syndrome. Cutis. 1998;61(3):128B.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Khalil S, Kurban M, Abbas O. Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management. J Am Acad Dermatol. 2022;87(3):614–622. doi: 10.1016/j.jaad.2020.05.113</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Abbas O, Kibbi AG, Chedraoui A, Ghosn S. Red scrotum syndrome: successful treatment with oral doxycycline. J Dermatolog Treat. 2008;19(6):1–2. doi: 10.1080/09546630802033858</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Narang T, Kumaran MS, Dogra S, Saikia UN, Kumar B. Red scrotum syndrome: idiopathic neurovascular phenomenon or steroid addiction? Sex Health. 2013;10(5):452–455. doi: 10.1071/SH13052</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Wollina U. Three orphans one should know: red scalp, red ear and red scrotum syndrome. J Eur Acad Dermatol Venereol. 2016;30(11):169–170. doi: 10.1111/jdv.13474.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Verma SB, Wollina U, Das A. A curious observation of passive transfer of steroid antifungal combination creams to the scrotum in patients of tinea cruris-Is this forme fruste of red scrotum syndrome? Dermatol Ther. 202033(6):14212. doi: 10.1111/dth.14212</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Khalil S, Kurban M, Abbas O. Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management. J Am Acad Dermatol. 2022;87(3):614–622. doi: 10.1016/j.jaad.2020.05.113</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Martinez JD, Soria Orozco M, Cardenas-de la Garza JA. Oral ivermectin for the treatment of red scrotum syndrome. J Dermatolog Treat. 2022;33(2):1102–1103. doi: 10.1080/09546634.2020.1773378</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Rapaport MJ, Rapaport VH. Serum nitric oxide levels in "red" patients: separating corticosteroid-addicted patients from those with chronic eczema. Arch Dermatol. 2004;140(8):1013–1014. doi: 10.1001/archderm.140.8.1013</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rapaport M. Rebound vasodilation from long-term topical corticosteroid use. Arch Dermatol. 2007;143(2):268–269. doi: 10.1001/archderm.143.2.268-b</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Prevost N, English JC. Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia.3 J Drugs Dermatol. 2007;6(9):935–936.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wollina U. Red scrotum syndrome. Dermatol Case Rep. 2011;5(3):38–41. doi: 10.3315/jdcr.2011.1072</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Markos AR, Dinsmore W. Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia? Int J STD AIDS. 2013;24(11):852–858. doi: 10.1177/0956462413489276</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Miller J, Leicht S. Pregabalin in the treatment of red scrotum syndrome: a report of two cases. Dermatol Ther. 2016;29(4):244–248. doi: 10.1111/dth.12354</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Mizes A, Bunimovich O, Bunimovich YuL. Combined carvedilol and gabapentin treatment induces a rapid response in red scrotum syndrome. Dermatol Online J. 2021;27(5). doi: 10.5070/D327553619</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Thompson GH, Hahn G, Rang M. Erythromelalgia. Clin Orthop Relat Res. 1979;(144):249–254.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Perry TW. Cutaneous microbial biofilm formation as an underlying cause of red scrotum syndrome. Eur J Med Res. 2021;26(1):95. doi: 10.1186/s40001-021-00569-9</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Romano C, Ghilardi A, Papini M. Nine male cases of tinea genitalis. Mycoses. 2005;48(3):202–204. doi: 10.1111/j.1439-0507.2005.01127.x</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Merhi R, Ayoub N, Mrad M. Carvedilol for the treatment of red scrotum syndrome. JAAD Case Rep. 2017;3(5):464–466. doi: 10.1016/j.jdcr.2017.06.021</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Griffin MO, Fricovsky E, Ceballos G, Villarreal F. Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol. 2010;299(3):539–548. doi: 10.1152/ajpcell.00047.2010</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Byun JW, Hong WK, Han SH, Song HJ, Lee HS, Choi GS, et al. Red scrotum syndrome: successful treatment with oral doxycycline. Int J Dermatol. 2012;51(3):362–363. doi: 10.1111/j.1365-4632.2010.04548.x</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Ceyhan AM, Gurses I, Yildirim M, Akkaya VB. A case of erythromelalgia: good response to treatment with gabapentin. J Drugs Dermatol. 2010;9(5):565–567.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Moore RA, Wiffen PJ, Derry S, Toelle T, Rice ASC. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2014(4):CD007938. doi: 10.1002/14651858.CD007938.pub3</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Cardenas-de la Garza JA, Villarreal-Villarreal CD, Cuellar-Barboza A, Cardenas-Gonzalez RE, Gonzalez-Benavides N, Cruz-Gomez LG, et al. Red Scrotum Syndrome Treatment with Pregabalin: A Case Series. Ann Dermatol. 2019;31(3):320–324. doi: 10.5021/ad.2019.31.3.320</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Toth C. Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain. Ther Adv Drug Saf. 2014;5(1):38–56. doi: 10.1177/2042098613505614</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173. doi: 10.1016/S1474-4422(14)70251-0</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Wang BCM, Liu D, Furnback WE, Bifa F, Dong P, Xie L, et al. The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China. Pain Ther. 2016;5(1):81–91. doi: 10.1007/s40122-016-0048-z</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Hwang AS, Costello CM, Yang YW. Rapid improvement of burning scrotum syndrome with indomethacin. JAAD Case Rep. 2021;12:32–33. doi: 10.1016/j.jdcr.2021.03.050</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Pyle TM, Heymann WR. Managing red scrotum syndrome (RSS) with topical timolol. Int J Dermatol. 2019;58(8):162–163. doi: 10.1111/ijd.14463</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Alzaid M, Al-Naseem A, Al-Niaimi F, Ali FR. Topical timolol in dermatology: infantile haemangiomas and beyond. Clin Exp Dermatol. 2022;47(5):819–832. doi: 10.1111/ced.15021</mixed-citation></ref></ref-list></back></article>
